Dr. Ben Goldacre:
PhUSE are excited to announce Dr. Ben Goldacre, author of 'Bad Pharma' as Keynote Speaker for the Annual Conference 2013.
Dr. Ben Goldacre is an award-winning Writer, Broadcaster and Medical Doctor who specalises in unpicking scientific claims made by scaremongering journalists, government reports, pharmaceutical corporations, PR companies and quacks. He trained in Medicine at Oxford and London and currently works as an Academic in Epidemiology.
Between 2003 - 2011 Ben wrote the Bad Science column within the Guardian and his book Bad Science (4th Estate) has sold over half a million copies worldwide, has been published in 25 languages and reached #1. In his new book, Bad Pharma (4th Estate, September 2012) Ben puts the $600bn global pharmaceutical industry under the microscope - what he reveals is a fascinating, terrifying mess.
Dr. Ben Goldacre will speak at the PhUSE conference about how patient centric thinking will help to bring efficacious new drugs to patients. In keeping with his latest book, Ben's keynote will share his views on the process of new drug approval. He will tell the PhUSE community how flaws in the planning, conduct and publication of studies conducted by the pharmaceutical industry can actually harm the life of patients.
Over the last few years, several requirements (such as the result reporting on clinicaltrials.gov) have been implemented with the good intention to increase the transparency and reduction of publication bias. Dr Ben Goldacre, will talk about the effectiveness of these changes, sharing his ideas on what additional necessary changes (e.g. increased data transparency as discussed in the EMA workshop in November 2012) need to be implemented in the drug approval process. His speech will cover all the involved parties: the patients, pharmaceutical drug companies, regulatory bodies and payers.
Dr. Ben Goldacre, (Copyright of John King 2012)
PhUSE are pleased to announce François Houÿez as the 2nd Keynote Speaker at our Annual Conference. François will present 'Patients Acting Against their Own Disease'.
François is the Director of Treatment Information and Access and Senior Advisor of Health Policy at the European Organisation for Rare Diseases (EURORDIS).
He joined the EURORDIS team in May 2003 and represents them at the Patients’ and Consumers’ Working Party at the European Medicines Agency (EMA) along with leading the Eurordis “Drug Information, Transparency and Access” task force.
François has worked as both a volunteer and employee for organisations fighting AIDS at both a national and international level since 1988. He will present at the PhUSE conference as both an industry professional and patient advocate.